Cross Country Healthcare (CCRN) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
21 Aug, 2026Opening remarks and agenda
The meeting was called to order by the CEO, who welcomed stockholders and outlined the agenda, including business matters and a Q&A session at the end.
The meeting was held virtually to increase inclusivity and participation.
Board and executive committee updates
Board members present included the Audit, Compensation, and Governance Committee chairs, as well as the CFO and General Counsel.
Outside legal counsel and the independent auditor were also in attendance.
Corporate governance
Broadridge Financial Solutions was appointed as inspector of elections, with the oath filed in the meeting minutes.
Meeting procedures and rules of conduct were outlined, and only validated stockholders could participate in Q&A.
The record date for voting was set as June 12, 2026, with 32,306,484 shares outstanding.
A quorum was established with approximately 72% of voting power represented.
Latest events from Cross Country Healthcare
- Shareholders to vote on a $13.25 per share cash merger, with board unanimous support.CCRN
Proxy filing - Shareholders to receive $13.25 per share in cash in a board-approved merger, pending approvals.CCRN
Proxy filing - Shareholders to vote on $437M all-cash acquisition by Knox Lane, with no operational changes expected.CCRN
Proxy filing - Transition to private ownership by Knox Lane at $13.25 per share, pending shareholder approval.CCRN
Proxy filing - Acquisition by Knox Lane will take the company private, focusing on value and continuity.CCRN
Proxy filing - Q1 2026 revenue dropped 17.8% and net loss widened, as merger plans to go private were announced.CCRN
Q1 2026 - All shares to be acquired for $13.25 cash in a $437M deal, pending shareholder approval.CCRN
Proxy filing - Q3 2024 revenue fell 29% year-over-year, with margin pressure but strong cash and diversification.CCRN
Q3 2024 - Q2 revenue dropped 37% with a net loss, but cash flow and liquidity remain strong.CCRN
Q2 2024